Schaffer Ashley, Puthenpura Vidya, Marshall Ian
Department of Pediatrics, Rutgers-Robert Wood Johnson Medical School, 89 French Street, New Brunswick, NJ 08901, USA.
Case Rep Endocrinol. 2016;2016:6210493. doi: 10.1155/2016/6210493. Epub 2016 May 31.
Hashimoto's thyroiditis (HT) and Graves' disease (GD) are the 2 most common autoimmune disease processes affecting the thyroid gland. The relationship between the two is complex and not clearly understood. It has been theorized that HT and GD are 2 separate disease processes due to unique genetic differences demonstrated by genome studies. On the other hand, based on occurrence of both HT and GD in monozygotic twins and within the same family, they have been regarded to represent 2 ends of the same spectrum. This case report describes 3 patients who presented with thyrotoxicosis due to both GD and HT. The initial presentation was thyrotoxicosis due to GD treated with antithyroid medication followed by temporary resolution. They all subsequently experienced recurrence of thyrotoxicosis in the form of Hashitoxicosis due to HT, and then eventually all developed thyrotoxicosis due to GD, requiring radioablation therapy.
桥本甲状腺炎(HT)和格雷夫斯病(GD)是影响甲状腺的两种最常见的自身免疫性疾病过程。两者之间的关系很复杂,尚未完全明确。基因组研究显示,由于独特的基因差异,理论上认为HT和GD是两个独立的疾病过程。另一方面,基于单卵双胞胎和同一家族中同时出现HT和GD的情况,它们被视为同一谱系的两端。本病例报告描述了3例因GD和HT而出现甲状腺毒症的患者。最初的表现是因GD导致的甲状腺毒症,接受抗甲状腺药物治疗后暂时缓解。随后,他们均因HT以桥本甲状腺毒症的形式再次出现甲状腺毒症复发,最终均因GD发展为甲状腺毒症,需要进行放射性消融治疗。